General Information of the Compound
| Compound ID |
CP0863038
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(2,6-difluorophenyl)-5-{3-[2-({2-methyl-3-[(4-methyl-1-piperazinyl)methyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}-2-(methyloxy)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C38H36F2N8O2
|
||||||||||||||||||
| Molecular Weight |
674.756
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(-c2nc3ccccn3c2-c2ccnc(Nc3cccc(CN4CCN(C)CC4)c3C)n2)cc1C(=O)Nc1c(F)cccc1F
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C38H36F2N8O2/c1-24-26(23-47-20-18-46(2)19-21-47)8-6-11-30(24)42-38-41-16-15-31(43-38)36-34(44-33-12-4-5-17-48(33)36)25-13-14-32(50-3)27(22-25)37(49)45-35-28(39)9-7-10-29(35)40/h4-17,22H,18-21,23H2,1-3H3,(H,45,49)(H,41,42,43)
Show/Hide
|
||||||||||||||||||
| InChIKey |
QMAMRLUBMABUFB-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01101, Insulin receptor
Protein ID: PT01104, Insulin-like growth factor 1 receptor